الفهرس 
Cardiac biomarkersOnly 14 pages are availabe for public view
 |  | from | 114 |  |  |
| | | from | 114 | | |
Abstract
This abundancy of cardiac biomarkers aided in early detection of AMI that lead to early management and saving of such patients, as well as their role in diagnosing AMI, it helped in predicting the time of onset of MI and prognosis of these patients, also predicting 30-days mortality.
In the intensive care unit (ICU), interpretation of biomarkers can be confounded by several conditions, including severity of the disease, coexisting organ dysfunction multiorgan involvement or altered synthesis or clearance.
It was found that those biomarkers not only of value in diagnosing AMI but they are beneficial in diagnosis and prognosing other medical conditions in the critically ill patients as in pulmonary dieasea like pulmonary embolism and AECOPD, kidney diseses as ESRD, neurolgic disorders as in ischemic stroke and in sepsis.
Despite apparent clinical need, currently available data are only beginning to define the potential role of cardiac biomarkers in the clinical ICU routine, so further research is needed to fully understand them and their utility in the ICU.